[Form 4] USA Rare Earth, Inc. Warrant Insider Trading Activity
USA Rare Earth, Inc. reported a Form 4 disclosing grants of restricted stock units to David Thomas Kronenfeld, the company's Chief Legal Officer and a director. The reporting shows three RSU awards, granted 08/13/2025, totaling 86,444 RSUs (27,298; 40,947; 18,199). Each RSU represents the right to receive one share of common stock on settlement. Vesting schedules differ: one award vests in two equal tranches on May 20, 2026 and May 20, 2027; a second vests in three equal tranches on May 20 of 2026, 2027 and 2028; the third is fully vested with underlying shares to be released on May 20, 2026. All reported RSUs are shown as direct beneficial ownership.
- Grants total 86,444 RSUs, showing clear compensation and retention alignment for the Chief Legal Officer
- Vesting schedules are multi‑year, which supports long‑term retention and alignment with shareholder interests
- Disclosure specifies direct beneficial ownership and settlement mechanics, providing transparency
- Potential dilution of common shares by 86,444 shares when RSUs settle
- Release and vesting dates may be deferred if they fall in closed trading windows, delaying investor visibility into share issuance timing
Insights
TL;DR: Insider received time‑based RSU awards totaling 86,444 shares, aligning executive pay with shareholder outcomes while adding potential dilution.
The Form 4 documents non‑derivative equity awards to the Chief Legal Officer and director, emphasizing retention through multi‑year vesting. Time‑based vesting that defers delivery until specific dates is a common governance tool to retain executives and align interests with long‑term performance. The disclosure shows direct ownership and explicit settlement mechanics, providing transparency on timing of share releases.
TL;DR: Grants are standard RSUs with staggered vesting: one award fully vested for release next year, others spread over two to three years.
The awards include one RSU tranche releasable in 2026, one with two equal tranches (2026, 2027) and one with three equal tranches (2026–2028). The filing clarifies that vesting may be delayed to the next open trading window if a scheduled vesting date falls in a closed window and that awards are governed by the company’s 2024 Omnibus Incentive Plan. These are routine, compensatory grants rather than transactional sales or purchases.